Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 219

1.

Gender differences of bleeding and stroke risk in very old atrial fibrillation patients on VKA treatment: results of the EPICA study on the behalf of FCSA (Italian Federation of Anticoagulation Clinics).

Poli D, Antonucci E, Testa S, Ageno W, Palareti G; FCSA (Italian Federation of Anticoagulation Clinics).

Thromb Res. 2013 Jan;131(1):12-6. doi: 10.1016/j.thromres.2012.10.009. Epub 2012 Nov 8.

PMID:
23141847
2.

Impact of glomerular filtration estimate on bleeding risk in very old patients treated with vitamin K antagonists. Results of EPICA study on the behalf of FCSA (Italian Federation of Anticoagulation Clinics).

Poli D, Antonucci E, Zanazzi M, Grifoni E, Testa S, Ageno W, Palareti G.

Thromb Haemost. 2012 Jun;107(6):1100-6. doi: 10.1160/TH11-10-0721. Epub 2012 Apr 26.

PMID:
22535516
3.

Bleeding risk in very old patients on vitamin K antagonist treatment: results of a prospective collaborative study on elderly patients followed by Italian Centres for Anticoagulation.

Poli D, Antonucci E, Testa S, Tosetto A, Ageno W, Palareti G; Italian Federation of Anticoagulation Clinics.

Circulation. 2011 Aug 16;124(7):824-9. doi: 10.1161/CIRCULATIONAHA.110.007864. Epub 2011 Aug 1.

4.

Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment.

Poli D, Antonucci E, Grifoni E, Abbate R, Gensini GF, Prisco D.

Thromb Haemost. 2009 May;101(5):938-42.

PMID:
19404548
5.

Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.

Taillandier S, Olesen JB, Clémenty N, Lagrenade I, Babuty D, Lip GY, Fauchier L.

J Cardiovasc Electrophysiol. 2012 Jul;23(7):708-13. doi: 10.1111/j.1540-8167.2011.02257.x. Epub 2012 Jan 23.

PMID:
22268375
6.

Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.

Gallego P, Roldán V, Torregrosa JM, Gálvez J, Valdés M, Vicente V, Marín F, Lip GY.

Circ Arrhythm Electrophysiol. 2012 Apr;5(2):312-8. doi: 10.1161/CIRCEP.111.967000. Epub 2012 Feb 7.

7.

Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.

Jacobs LG, Billett HH, Freeman K, Dinglas C, Jumaquio L.

Am J Geriatr Pharmacother. 2009 Jun;7(3):159-66. doi: 10.1016/j.amjopharm.2009.06.002.

PMID:
19616184
8.

Stroke and major bleeding risk in elderly patients aged ≥75 years with atrial fibrillation: the Loire Valley atrial fibrillation project.

Lip GY, Clementy N, Pericart L, Banerjee A, Fauchier L.

Stroke. 2015 Jan;46(1):143-50. doi: 10.1161/STROKEAHA.114.007199. Epub 2014 Nov 25.

9.

Oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and risk of bleeding. A Multicenter Inception Cohort Study.

Pengo V, Legnani C, Noventa F, Palareti G; ISCOAT Study Group.(Italian Study on Complications of Oral Anticoagulant Therapy).

Thromb Haemost. 2001 Mar;85(3):418-22.

PMID:
11307807
10.

The predictive ability of bleeding risk stratification models in very old patients on vitamin K antagonist treatment for venous thromboembolism: results of the prospective collaborative EPICA study.

Poli D, Antonucci E, Testa S, Cosmi B, Palareti G, Ageno W; FCSA Italian Federation of Anticoagulation Clinics.

J Thromb Haemost. 2013 Jun;11(6):1053-8. doi: 10.1111/jth.12239.

11.

Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.

Agarwal S, Bennett D, Smith DJ.

Am J Cardiovasc Drugs. 2010;10(1):37-48. doi: 10.2165/11318870-000000000-00000.

PMID:
20104933
12.

Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients.

Roldán V, Marín F, Muiña B, Torregrosa JM, Hernández-Romero D, Valdés M, Vicente V, Lip GY.

J Am Coll Cardiol. 2011 Jun 21;57(25):2496-504. doi: 10.1016/j.jacc.2010.12.033. Epub 2011 Apr 14.

13.

Efficacy and safety of vitamin K-antagonists (VKA) for atrial fibrillation in non-dialysis dependent chronic kidney disease.

Kooiman J, van Rein N, Spaans B, van Beers KA, Bank JR, van de Peppel WR, del Sol AI, Cannegieter SC, Rabelink TJ, Lip GY, Klok FA, Huisman MV.

PLoS One. 2014 May 9;9(5):e94420. doi: 10.1371/journal.pone.0094420. eCollection 2014.

14.

Diagnosis and management of atrial fibrillation by primary care physicians in Italy : a retrospective, observational analysis.

Piccinocchi G, Laringe M, Guillaro B, Arpino G, Piccinocchi R, Nigro G, Calabrò P.

Clin Drug Investig. 2012 Nov;32(11):771-7. doi: 10.1007/s40261-012-0005-5.

15.

Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.

Friberg L, Rosenqvist M, Lip GY.

Eur Heart J. 2012 Jun;33(12):1500-10. doi: 10.1093/eurheartj/ehr488. Epub 2012 Jan 13.

PMID:
22246443
16.

Bleeding risk during oral anticoagulation in atrial fibrillation patients older than 80 years.

Poli D, Antonucci E, Grifoni E, Abbate R, Gensini GF, Prisco D.

J Am Coll Cardiol. 2009 Sep 8;54(11):999-1002. doi: 10.1016/j.jacc.2009.05.046.

17.

Bleeding complications associated with warfarin treatment in ischemic stroke patients with atrial fibrillation: a population-based cohort study.

Seet RC, Rabinstein AA, Christianson TJ, Petty GW, Brown RD Jr.

J Stroke Cerebrovasc Dis. 2013 May;22(4):561-9. doi: 10.1016/j.jstrokecerebrovasdis.2013.01.019. Epub 2013 Mar 15.

18.

Risk of falls and major bleeds in patients on oral anticoagulation therapy.

Donzé J, Clair C, Hug B, Rodondi N, Waeber G, Cornuz J, Aujesky D.

Am J Med. 2012 Aug;125(8):773-8. doi: 10.1016/j.amjmed.2012.01.033.

PMID:
22840664
20.

Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score?

Ruiz-Nodar JM, Marín F, Roldán V, Valencia J, Manzano-Fernández S, Caballero L, Hurtado JA, Sogorb F, Valdés M, Lip GY.

Circ Cardiovasc Interv. 2012 Aug 1;5(4):459-66. doi: 10.1161/CIRCINTERVENTIONS.112.968792. Epub 2012 Jul 10.

Supplemental Content

Support Center